Cargando…
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics
Broad-based cognitive deficits are an enduring and disabling symptom for many patients with severe mental illness, and these impairments are inadequately addressed by current medications. While novel drug targets for schizophrenia and depression have emerged from recent large-scale genome-wide assoc...
Ejemplares similares
-
Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood
por: Hatzimanolis, Alex, et al.
Publicado: (2015) -
Erratum: GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium
por: Trampush, J W, et al.
Publicado: (2017) -
GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium
por: Trampush, J W, et al.
Publicado: (2017) -
Molecular Genetic Evidence for Genetic Overlap between General Cognitive Ability and Risk for Schizophrenia: A Report from the Cognitive Genomics Consortium (COGENT)
por: Lencz, Todd, et al.
Publicado: (2013) -
Variation in Psychosis Gene ZNF804A Is Associated With a Refined Schizotypy Phenotype but Not Neurocognitive Performance in a Large Young Male Population
por: Stefanis, Nicholas C., et al.
Publicado: (2013)